Further functional assays confirmed that PRDX6 significantly promoted proliferation, migration, and invasion in both ER‐positive BRCA cells (MCF‐7) and TNBC cells (SUM159PT), and significantly accelerated tumor growth in vivo, supporting its oncogenic role irrespective of BRCA subtype. The gene discussed is ESR1; the disease is neoplasm.